Global Leading Market Research Publisher QYResearch announces the release of its latest report “Veterinary Multivitamins – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Veterinary Multivitamins market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Veterinary Multivitamins was estimated to be worth US1,250millionin2025andisprojectedtoreachUS1,250millionin2025andisprojectedtoreachUS 1,850 million, growing at a CAGR of 5.5% from 2026 to 2032. Veterinary multivitamins are dietary supplements containing a combination of essential vitamins (A, D, E, K, B-complex, C) and minerals (calcium, phosphorus, zinc, copper, selenium) formulated for livestock (cattle, sheep, pigs, poultry, horses), companion animals (dogs, cats), and zoo animals. Key functions include immune support (vitamin A, C, E, selenium), bone development (vitamin D, calcium, phosphorus), nervous system function (B-complex), red blood cell formation (B12, folic acid, iron), antioxidant protection (vitamin E, selenium), and overall growth and productivity (weight gain, milk yield, egg production, fertility). The market is driven by rising livestock production (meat, milk, eggs), increasing companion animal ownership (70M dogs, 80M cats in US alone), intensive farming practices (confinement, high stocking density, stress), and growing awareness of nutrition’s role in animal health, performance, and disease prevention. Industry pain points include vitamin stability (oxidation, heat, moisture, light, 10-30% potency loss over shelf life), palatability (bitter taste, reduced feed intake, 5-15%), and dosage accuracy (overdose toxicity, 0.5-2% adverse events).
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5973721/veterinary-multivitamins
1. Recent Industry Data and Animal Nutrition Trends
Between Q4 2025 and Q2 2026, the veterinary multivitamins sector has witnessed steady growth driven by livestock production, companion animal humanization, and intensive farming. In January 2026, the global animal nutrition market reached 55B(multivitamins2.355B(multivitamins2.31.25B), growing 6% YoY. According to animal health data, powder formulations hold 50% market share (feed additive, bulk, cost-effective), liquid 35% (drinking water, fast absorption, higher bioavailability), others 15% (tablets, chews, pastes, injectables). Global cattle population 1.5B head, sheep/goats 2.2B, pigs 1.0B, poultry 25B, dogs 500M, cats 400M. EU’s Organic Farming Regulation (March 2026) restricts synthetic vitamins (prefers natural sources), US AAFCO updates vitamin requirements (April 2026) for complete and balanced pet food.
2. User Case – Powder vs. Liquid vs. Other Formulations
A comprehensive animal nutrition study (n=700 livestock farms, veterinary practices across 15 countries) revealed distinct product requirements:
- Powder (50% market share, 5.5% CAGR): Dry powder (micronized, free-flowing). Mixed into feed (premix, top-dress, complete feed), 50-500g/ton. Lower cost $2-10/kg. Shelf life 12-24 months. Used for livestock (cattle, pigs, poultry, sheep, goats). Growing at 5.5% CAGR.
- Liquid (35% market share, 6% CAGR): Solution or suspension (water-soluble). Added to drinking water (dosage 1-10mL/L), faster absorption, higher bioavailability. Used for young animals (piglets, calves, chicks), sick animals (anorexia, reduced feed intake), poultry, swine. Higher cost $10-30/L. Growing at 6% CAGR.
- Others (15% market share, 4.5% CAGR): Tablets, chewable, soft chews (companion animals). Pastes, gels, injectables (livestock, zoo animals, individualized dosing). Cost $5-50 per dose. Growing at 4.5% CAGR.
Case Example – Poultry (Brazil, 10B birds/year): Brazilian broiler operation adds powder multivitamin (A, D3, E, B12, K, riboflavin, niacin, pantothenic acid, choline, 200g/ton feed, $5/kg) to prevent deficiency, improve growth, feed conversion (FCR 1.5-1.6). Challenge: vitamin stability (heat, moisture, oxidation, 10-20% loss). Stabilized forms (microencapsulated, protected), stability improved.
Case Example – Swine (US, 100M pigs/year): Nursery piglets (weaning stress, reduced feed intake) receive liquid multivitamins (A, D3, E, B-complex, 5mL/L drinking water, 7 days, $20/L). Reduces diarrhea (10-20%), improves weight gain (5-10%), reduces mortality (1-3%). Challenge: water line biofilm (bacteria, yeast). Acidifiers (citric acid, phosphoric acid) + sanitizers (chlorine, hydrogen peroxide).
Case Example – Companion Animal (US, 80M dogs): Senior dog (arthritis, immune decline) receives chewable multivitamin (A, C, D3, E, B-complex, glucosamine, chondroitin, MSM, $30/month). Joint health (glucosamine + chondroitin), antioxidant protection (vitamin C, E), immune support (zinc, selenium). Challenge: palatability (bitter taste, 5-10% refusal). Flavoring (chicken, beef, liver, peanut butter, bacon, cheese).
3. Technical Differentiation and Manufacturing Complexity
Veterinary multivitamins involve vitamin blending, stability enhancement, and regulatory compliance:
- Vitamin premix: Fat-soluble (A, D3, E, K, stabilized, coated). Water-soluble (B-complex: B1, B2, B3, B5, B6, B7, B9, B12; C). Minerals (calcium, phosphorus, magnesium, zinc, copper, manganese, selenium, iodine, cobalt, iron). Carriers (calcium carbonate, wheat middlings, rice hulls, corn cob, soybean hulls).
- Stability enhancement: Microencapsulation (gelatin, starch, lipid, 10-50μm). Coating (ethylcellulose, hydrogenated vegetable oil). Antioxidants (BHA, BHT, ethoxyquin, vitamin E, rosemary extract, 50-500ppm). Chelation (minerals, amino acids, proteinates, organic acids).
- Quality control: Vitamin assay (HPLC, UPLC). Mineral assay (ICP, AAS). Stability (accelerated 40°C/75% RH, 3-6 months). Uniformity (mix, 5-10% CV). Purity (heavy metals, arsenic, lead, cadmium, mercury). Microbial (salmonella, E. coli, total plate count). Label claim (90-150% of declared). Shelf life (12-24 months).
- Regulatory compliance: FDA (US) CVM, AAFCO (pet food, animal feed). EU (EC) 1831/2003 (feed additives), 767/2009 (marketing, use). China MARA (Ministry of Agriculture and Rural Affairs). GMP (good manufacturing practice). Hazard Analysis Critical Control Point (HACCP).
Exclusive Observation – Powder vs. Liquid vs. Chewables: Powder (50% share, 5.5% CAGR, feed additive, bulk, livestock). Liquid (35% share, 6% CAGR, drinking water, faster absorption, young/sick animals). Chewables/tablets (15% share, 4.5% CAGR, companion animals, individualized dosing). Global leaders (Rx Vitamins, Nutri-Vet, Vet’s Best, Pet Naturals, FoodScience, VITA-gen, Moral Pharma, Natural Dog) dominate companion animal multivitamins (chewables, soft chews, tablets), margins 20-30%. Chinese manufacturers (Hebei Kexing) have scaled rapidly (30-40% of global volume) with cost advantage 30-50% lower (1−3/kgvs.1−3/kgvs.5-10/kg), but lower stability (10-20% loss vs. 5-10%), less quality control. As livestock production intensifies (confinement, high stocking density, stress), demand for liquid multivitamins (drinking water, fast absorption, 6% CAGR) will grow. Companion animal humanization (pet parents, 70-80% treat pets as family) drives demand for premium multivitamins (organic, natural, non-GMO, 8-10% CAGR).
4. Competitive Landscape and Market Share Dynamics
Key players: Rx Vitamins (12% share – US, companion animal), Nutri-Vet (10% – US, dog/cat), Vet’s Best (8% – US, pet health), Pet Naturals (7% – US), VITA-gen Laboratories (6% – US), Moral Pharma (5% – India), others (52% – Vetark, Natural Dog, FoodScience, Hebei Kexing, Chinese manufacturers).
Segment by Formulation: Powder (50% market share), Liquid (35%, fastest-growing 6% CAGR for young/sick animals), Others (15%, 4.5% CAGR for companion animals).
Segment by End-User: Farm (60% – cattle, pigs, poultry, sheep, goats), Zoo (10% – exotic animals, wildlife conservation), Others (30% – companion animals (dogs, cats, horses), laboratory animals, aquaculture).
5. Strategic Forecast 2026-2032
We project the global veterinary multivitamins market will reach 1,850millionby2032(5.51,850millionby2032(5.55.50-6.50/kg (liquid premium offset by powder commoditization). Key drivers:
- Livestock production growth (meat, milk, eggs): Global meat consumption 360M tons (2025) → 400M tons (2032). Milk 900M tons → 1,000M tons. Eggs 80M tons → 95M tons. Multivitamins essential for growth (weight gain +5-10%, FCR improvement 5-10%), reproduction (fertility +10-20%), immunity (disease resistance 20-30%).
- Intensive farming (confinement, high stocking density, stress): High stress → reduced feed intake, nutrient absorption, immune function. Multivitamins (liquid, drinking water) for rapid correction.
- Companion animal humanization (pet parents): 70-80% of pet owners treat pets as family, willing to spend on premium nutrition. Organic, natural, non-GMO, grain-free, limited ingredient, functional (joint, skin, coat, dental, cognitive, immune, digestive, urinary, cardiac), 8-10% CAGR.
- Zoo and wildlife conservation (exotic animals, captive breeding): Endangered species (panda, rhino, gorilla, orangutan, elephant) require tailored multivitamins (vitamin D for indoor animals, vitamin E for captive diets). 5-7% CAGR.
Risks include vitamin stability (oxidation, heat, moisture, light, 10-30% loss over shelf life), palatability (bitter taste, reduced feed intake, 5-15%), and dosage toxicity (overdose, 0.5-2% adverse events, hypervitaminosis A/D, liver/kidney damage). Manufacturers investing in liquid formulations (6% CAGR), stabilized vitamins (microencapsulated, coated, 5-10% loss), and palatability enhancers (flavors, sweeteners, masking agents) will capture share through 2032.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
